Edward W. Unkart

Edward W. Unkart has served as a member of KalVista’s Board of Directors since the consummation of the Carbylan Therapeutics, Inc. transaction in 2016. From August 2006 to August 2009, Mr. Unkart served as a member of the Board of Directors of XTENT, a publicly traded manufacturer of drug-eluting stent systems, where he was the Chair of the company’s audit committee and a member of the nominating and governance committee. From October 2004 to June 2009, Mr. Unkart served as a member of the Board of Directors of VNUS Medical Technologies, a publicly traded medical device company, where he was the Chair of the company’s audit committee and a member of the compensation committee. From January 2005 to December 2008, Mr. Unkart served as Vice President of Finance and Administration and Chief Financial Officer of SurgRx; a manufacturer of medical devices. Mr. Unkart is a Certified Public Accountant and holds a BS and an MBA from Stanford University.